tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Ocuphire Pharma (OCUP)
NASDAQ:OCUP
OCUP
Ocuphire Pharma
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding OCUP?
Track your performance easily
Link Broker

Ocuphire Pharma (OCUP) Stock News & Sentiment

986 Followers
Ocuphire Pharma Merges with Opus Genetics, Renamed Opus Genetics
Premium
Company Announcements
Ocuphire Pharma Merges with Opus Genetics, Renamed Opus Genetics
2M ago
8K
OCUP
OCUP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OCUP Earnings this Week: How Will it Perform?
5M ago
OCUP
Ocuphire Pharma Gambles on Cash-Pay Strategy for RYZUMVI: Is It a Path to Profit or a Financial Pitfall?
Premium
Company Announcements
Ocuphire Pharma Gambles on Cash-Pay Strategy for RYZUMVI: Is It a Path to Profit or a Financial Pitfall?
7M ago
OCUP
Ocuphire Pharma Shares Updates in Upcoming Investor Meetings
Premium
Company Announcements
Ocuphire Pharma Shares Updates in Upcoming Investor Meetings
8M ago
8K
OCUP
OCUP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OCUP Earnings this Week: How Will it Perform?
8M ago
OCUP
Ocuphire Pharma Incentivizes Director Pepose with Stocks and Options
Premium
Company Announcements
Ocuphire Pharma Incentivizes Director Pepose with Stocks and Options
8M ago
8K
OCUP
Ocuphire Pharma Engages Investors with Presentation Update
Premium
Company Announcements
Ocuphire Pharma Engages Investors with Presentation Update
9M ago
8K
OCUP
More OCUP News >

OCUP News on the Web

Ocuphire Pharma rating placed under review at H.C. Wainwright
The Fly
Neutral
Ocuphire Reports Positive Data For Phase 3 Trial Of Ryzumvi In Induced Mydriasis
rttnews
Neutral
Ocuphire Pharma Announces Publication of Full Phase 3 Results of Phentolamine Ophthalmic Solution 0.75% for Pharmacologically-Induced Mydriasis in Ophthalmology
Yahoo Finance
Neutral
UPDATE – Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Yahoo Finance
Neutral
Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia
Yahoo Finance
Neutral
Ocuphire Pharma, Inc. Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Yahoo Finance
Neutral
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
InvestorPlace
Neutral
Ocuphire Pharma, Inc. (OCUP) Reports Q2 Loss, Lags Revenue Estimates
Zacks
Neutral

News Score - Last 7 Days

Neutral
OCUP
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OCUP’s Media Buzz Sentiment?
1 articles about OCUP were published this week. In an average week, 1 articles are published.
    What is OCUP’s weekly average amount of articles?
    In an average week, 1 articles about OCUP are published.
      What is OCUP’s News Sentiment?
      50% of articles about OCUP were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        STESteris
        ICLRIcon
        WSTWest Pharmaceutical Services
        BPMCBlueprint Medicines
        INZYInozyme Pharma
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing